NCT00060567View on ClinicalTrials.gov

Dose-Finding Study of E7070 in Combination With Irinotecan

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Cancer
Interventions
DRUG

E7070 + irinotecan combination

Escalating doses starting from 125 mg/m2 irinotecan plus 250 mg/m2 E7070 combination.

DRUG

Irinotecan + E7070 combination

Escalating doses starting from 100 mg/m2 irinotecan plus 400 mg/m2 E7070 combination.

DRUG

Irinotecan + E7070 combination

Escalating doses starting from 100 mg/m2 irinotecan plus 400 mg/m2 E7070 combination.

Trial Locations (1)

Unknown

Boston

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00060567 - Dose-Finding Study of E7070 in Combination With Irinotecan | Biotech Hunter | Biotech Hunter